Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.

The GIHU004 study was designed to evaluate the safety and immunogenicity of three doses of DermaVir immunization in HIV-infected subjects on fully suppressive combination antiretroviral therapy (cART).This first-in-human dose escalation study was conducted with three topical DermaVir doses targeted...

Full description

Bibliographic Details
Main Authors: Julianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, Dénes Bánhegyi, János Szlávik, Eszter Ujhelyi, Enikő R Tőke, Levente Molnár, Zsolt Lisziewicz, Brigitte Autran, Franco Lori
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3348904?pdf=render